Wedge Capital Management L L P NC boosted its stake in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 9.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 107,165 shares of the company's stock after buying an additional 9,660 shares during the quarter. Wedge Capital Management L L P NC owned approximately 0.20% of Molina Healthcare worth $35,299,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. Rothschild Investment LLC boosted its position in Molina Healthcare by 126.3% during the first quarter. Rothschild Investment LLC now owns 86 shares of the company's stock valued at $28,000 after acquiring an additional 48 shares during the last quarter. Colonial Trust Co SC boosted its position in shares of Molina Healthcare by 930.0% during the 4th quarter. Colonial Trust Co SC now owns 103 shares of the company's stock valued at $30,000 after purchasing an additional 93 shares in the last quarter. Wingate Wealth Advisors Inc. bought a new stake in shares of Molina Healthcare during the 4th quarter valued at about $52,000. Hurley Capital LLC acquired a new stake in Molina Healthcare during the fourth quarter worth approximately $55,000. Finally, EverSource Wealth Advisors LLC grew its stake in Molina Healthcare by 81.5% during the fourth quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock worth $57,000 after purchasing an additional 88 shares during the period. Institutional investors own 98.50% of the company's stock.
Molina Healthcare Stock Performance
Shares of NYSE MOH traded down $0.02 during midday trading on Monday, hitting $296.87. 438,633 shares of the company's stock traded hands, compared to its average volume of 684,610. The firm has a fifty day moving average of $320.53 and a 200 day moving average of $307.36. Molina Healthcare, Inc. has a 1 year low of $262.32 and a 1 year high of $365.23. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. The stock has a market capitalization of $16.09 billion, a price-to-earnings ratio of 14.53, a price-to-earnings-growth ratio of 1.06 and a beta of 0.56.
Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, topping analysts' consensus estimates of $5.96 by $0.12. The business had revenue of $11.15 billion during the quarter, compared to analysts' expectations of $10.86 billion. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. The business's quarterly revenue was up 12.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $5.73 earnings per share. On average, analysts forecast that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.
Analyst Ratings Changes
A number of equities analysts have recently issued reports on MOH shares. Mizuho increased their price objective on shares of Molina Healthcare from $376.00 to $400.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Morgan Stanley assumed coverage on Molina Healthcare in a report on Monday. They issued an "overweight" rating and a $364.00 price target on the stock. Wall Street Zen upgraded Molina Healthcare from a "hold" rating to a "buy" rating in a report on Friday, April 11th. Truist Financial increased their target price on Molina Healthcare from $340.00 to $400.00 and gave the stock a "buy" rating in a report on Friday, April 11th. Finally, Wells Fargo & Company raised shares of Molina Healthcare from an "equal weight" rating to an "overweight" rating and lifted their price target for the company from $295.00 to $372.00 in a research report on Wednesday, March 5th. Nine investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $364.21.
View Our Latest Research Report on MOH
Insiders Place Their Bets
In related news, Director Richard M. Schapiro sold 669 shares of Molina Healthcare stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total value of $214,414.50. Following the completion of the transaction, the director now owns 11,244 shares in the company, valued at $3,603,702. The trade was a 5.62% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the company's stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total value of $28,005,250.00. Following the transaction, the chief executive officer now directly owns 257,715 shares of the company's stock, valued at approximately $82,484,262.90. The trade was a 25.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.10% of the stock is owned by insiders.
About Molina Healthcare
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Articles

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.